Featured Research

from universities, journals, and other organizations

Deficiencies Common In Radiation Therapy Trial Reports For Hodgkin’s, Non-Hodgkin's Lymphoma

Date:
February 4, 2009
Source:
American Society for Therapeutic Radiology and Oncology
Summary:
Reporting of radiation therapy details in randomized controlled trials for Hodgkin's and non-Hodgkin's lymphoma is deficient due to a lack of reporting of key radiation therapy descriptors and quality assurance processes designed to ensure the accuracy and reproducibility of treatment regimens, according to a new study.

Reporting of radiation therapy details in randomized controlled trials for Hodgkin’s and non-Hodgkin’s lymphoma is deficient due to a lack of reporting of key radiation therapy descriptors and quality assurance processes designed to ensure the accuracy and reproducibility of treatment regimens, according to a February 1 study in the International Journal of Radiation Oncology Biology Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

Randomized controlled trial reports are the primary source of trial documentation that is available to clinicians and patients, and complete descriptions of the therapies used are necessary for proper interpretation and replication of the trials.

In 1996, the Consolidated Standards of Reporting Trials statement was developed to ensure that future readers of a trial report were able to draw informed conclusions about the accuracy and validity of trials.

However, there has been little research on how oncology trials are reported.

As a result, researchers from the Memorial Sloan-Kettering Cancer Center Department of Radiation Oncology in New York sought to determine the quality of radiation therapy reporting in randomized controlled trials involving Hodgkin’s and non-Hodgkin’s lymphoma.

The study authors reviewed 61 trial reports that were published between 1998 and 2007 and assessed them for the presence of six quality measures: target volume, radiation dose, fractionation, radiation prescription, quality assurance process use and adherence to quality assurance.

Only one-third of the reports described radiation target volume, only 20 percent described using a quality assurance process and 11 percent described adherence to quality assurance.

“Inadequate reporting of radiation therapy details was found regardless of disease stage, cooperative group sponsorship, journal of publication or country of origin,” Justin E. Bekelman, M.D., lead author of the study who is now an assistant professor of radiation oncology at the University of Pennsylvania, said.

The study authors also suggested that consensus standards for radiation therapy reporting should be developed and integrated into the peer-review process.


Story Source:

The above story is based on materials provided by American Society for Therapeutic Radiology and Oncology. Note: Materials may be edited for content and length.


Cite This Page:

American Society for Therapeutic Radiology and Oncology. "Deficiencies Common In Radiation Therapy Trial Reports For Hodgkin’s, Non-Hodgkin's Lymphoma." ScienceDaily. ScienceDaily, 4 February 2009. <www.sciencedaily.com/releases/2009/02/090204144305.htm>.
American Society for Therapeutic Radiology and Oncology. (2009, February 4). Deficiencies Common In Radiation Therapy Trial Reports For Hodgkin’s, Non-Hodgkin's Lymphoma. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2009/02/090204144305.htm
American Society for Therapeutic Radiology and Oncology. "Deficiencies Common In Radiation Therapy Trial Reports For Hodgkin’s, Non-Hodgkin's Lymphoma." ScienceDaily. www.sciencedaily.com/releases/2009/02/090204144305.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins